Considering that EVPL and ENTPD3 were closely related to immune cell infiltration, immune checkpoints, and microsatellite instability (MSI) status of CRC, we speculated that EVPL and ENTPD3 may serve as predictive biomarkers for CRC immunotherapy. The gene discussed is ENTPD3; the disease is colorectal carcinoma.